Reggenerate logo
SKIN & HAIR

Oral Hyaluronic Acid: Which Form and What Dose?

11 Nov 2026 • 8 min read

By Chloé Vernet, Sales & Marketing Manager at Circul'Egg

In rats, almost all the radioactivity from a dose of labeled hyaluronic acid comes out in the feces. And yet several placebo-controlled trials in humans measure an effect on skin hydration at 120 mg per day. This paradox sums up oral hyaluronic acid well: an active everyone knows from serums, but whose form, dose and regulatory status in supplements remain unclear to many brands.

Most trials of oral hyaluronic acid use 60 to 200 mg per day, for 6 to 12 weeks for skin and up to 12 months for joints. They have covered a very wide range of molecular weights, from 2 kDa to 1.8 MDa, with none standing out clearly. In Europe, hyaluronic acid has no authorized health claim: your on-pack message will have to rely on other nutrients.

Where does the hyaluronic acid in food supplements come from?

Hyaluronic acid is a glycosaminoglycan whose structure is the same whatever its origin. What changes from one supplier to the next is chain length, purity and the matrix that comes with it.

Historically extracted from animal tissues such as rooster comb, it is now produced mainly by bacterial fermentation, in particular with Streptococcus equi subsp. zooepidemicus, a natural producer, and now also with modified microorganisms (de Oliveira et al., 2016). Three families coexist on the market:

  • Fermentation-derived sodium hyaluronate, very pure, available in a wide range of molecular weights.
  • Rooster comb extract, a matrix in which hyaluronic acid accounts for 60 to 80% according to the European specification, alongside other glycosaminoglycans and proteins.
  • Matrices that contain it naturally, such as eggshell membrane. An analysis by liquid chromatography and mass spectrometry showed that hyaluronic acid is the most abundant glycosaminoglycan in it (Liu et al., 2016). This study gives no content per gram of native membrane, and we will refrain from putting one forward.

Molecular weight: should you choose a “low” or “high” hyaluronic acid?

It is the argument suppliers push the most, and the one on which the literature is the least settled.

In rats, 86.7 to 95.6% of the radioactivity from a technetium-labeled high-molecular-weight hyaluronic acid was recovered in excreta, almost entirely fecal; in both rats and dogs, a fraction was nonetheless detected in connective tissues, including joints and skin (Balogh et al., 2008). Another team found no 300 kDa hyaluronic acid in rat feces: it would be degraded by colonic bacteria into oligosaccharides, absorbed in the large intestine and then distributed as far as the skin (Kimura et al., 2016). A third avenue does without absorption altogether: in mice, a 900 kDa hyaluronic acid binds to the TLR-4 receptor of the intestinal epithelium and modulates immune signals (Asari et al., 2010). All of this remains demonstrated in animals.

In humans, the trials that compared two molecular weights did not name a winner. At 120 mg per day, 2 kDa and 300 kDa both outperformed placebo on wrinkles, with 300 kDa reaching significance earlier (Oe et al., 2017); 800 kDa and 300 kDa both improved hydration (Kawada et al., 2014). Frankly, we recommend that our clients not build their sales argument on molecular weight alone. Instead, ask the supplier for the measured value, the analytical method and the clinical trial that matches that precise form.

What doses have been studied, for skin and for joints?

For skin, 120 mg per day comes up in most randomized double-blind trials. The most recent, conducted in 150 Caucasian adults with a 1.8 MDa sodium hyaluronate, compared 60 and 120 mg: the effects on hydration, elasticity and periorbital wrinkles were clearer at 120 mg (Dolečková et al., 2025). It suggests a dose effect, in a European population, where most of the data had come from Asia.

For joints, the data are thinner and more mixed. The longest trial followed 60 people with knee osteoarthritis for 12 months, at 200 mg per day, with a muscle-strengthening program in both groups: symptoms improved in both arms, and the difference from placebo was significant only in those aged 70 and under, at months 2 and 4 (Tashiro et al., 2012). A drink combining 50 mg of hyaluronic acid, 750 mg of glucosamine and 250 mg of chondroitin, tested for 8 weeks in 80 people with moderate knee pain, did no better than placebo (Wang et al., 2021).

TrialPopulationDose and formDurationMain result
Kawada et al., 201461 adults with dry skin120 mg, 800 or 300 kDa6 weeksHydration superior to placebo
Oe et al., 201760 adults with crow's feet wrinkles120 mg, 2 or 300 kDa12 weeksWrinkles reduced, significant from 8 weeks at 300 kDa
Hsu et al., 202140 adults aged 35 to 64120 mg12 weeksWrinkles, hydration and elasticity improved
Dolečková et al., 2025150 Caucasian adults60 or 120 mg, 1.8 MDa12 weeksClearer effects at 120 mg
Tashiro et al., 201260 people with knee osteoarthritis200 mg plus exercise12 monthsSignificant in those aged 70 and under, at months 2 and 4
Kalman et al., 200820 people with knee osteoarthritis80 mg of rooster comb extract8 weeksPrimary endpoint (pain) not significant

Let us be honest about the limitations: these trials remain modest in size, often funded by hyaluronic acid producers, and a recent meta-analysis on photoaging found no significant benefit of oral hyaluronic acid on skin elasticity or on minimal erythema dose (Yang et al., 2025). The most consistent signal concerns skin hydration. For joints, oral hyaluronic acid comes across as a supporting active; our comparison of joint supplement ingredients details the other options.

What is its regulatory status in Europe?

Novel food or not: it all depends on the source

Consulted under Article 4 of Regulation (EU) 2015/2283, the European Commission concluded in 2023 that a sodium hyaluronate obtained by fermentation of a non-genetically modified strain of Streptococcus equi subsp. zooepidemicus is not a novel food in food supplements (March 2023 summary). This conclusion applies to that process and that use: a different strain or a different food category calls for verification.

Rooster comb extract, for its part, was authorized as a novel ingredient in 2013 for milk-based drinks, yogurt-type products and fresh cheese (Implementing Decision 2013/705/EU), following an EFSA opinion that judged it safe up to 80 mg per day, excluding pregnant women and children (EFSA, 2013). Some Member States also regulate doses: in Denmark, the DTU institute concluded in 2023 that an intake of 64 mg per day of fermentation-derived hyaluronic acid would not cause adverse effects in adults (DTU, 2023). So check the rules in each country where you sell.

Claims: none is authorized

EFSA issued a negative opinion on hyaluronic acid and the maintenance of joints in 2009 (EFSA, 2009), then on protection of the skin against dehydration in 2012 (EFSA, 2012). The claim “helps to maintain good skin hydration” is among those rejected by Regulation (EU) No 1066/2013. A brand therefore cannot promise hydrated skin thanks to hyaluronic acid.

The on-pack message is built with authorized nutrients: vitamin C, which contributes to normal collagen formation for the normal function of skin, or biotin, zinc, niacin, riboflavin and vitamin A, which contribute to the maintenance of normal skin. Always check the exact wording in the EU register of claims before printing.

Capsule, gummy or drink: how should you formulate it?

At 60 to 200 mg per day, hyaluronic acid fits without difficulty into a single capsule or tablet. It is the simplest format for reproducing the dose of a published trial as is.

Gummies require more attention. Hyaluronic acid chains can fragment under heat and acidity, two usual conditions of cooking and gelling. If molecular weight is part of your sales argument, demand stability data in a matrix comparable to yours. And we advise against featuring hyaluronic acid on a gummy that would contain only a few milligrams: the benchmark in skin trials remains 60 to 120 mg.

In a drink or a shot, viscosity becomes the first criterion: a high molecular weight thickens water considerably, while shorter forms dissolve more easily. Check that the formula holds up over its entire shelf life.

Where does eggshell membrane fit in?

It does not play in the same category as pure sodium hyaluronate, and it would be misleading to present it as a dosed source of hyaluronic acid. Its logic is that of a matrix: in it, hyaluronic acid sits alongside collagen, elastin, glucosamine and chondroitin.

At Circul'Egg, we chose to keep this matrix intact. Reggenerate®, native eggshell membrane, is separated from upcycled eggshells by a 100% mechanical, solvent-free process, and remains non-hydrolyzed. It naturally provides type I, V and X collagen, elastin, hyaluronic acid, glucosamine and chondroitin, at 300 mg per day, a dose compatible with capsules, tablets, gummies, powders and bars. The published trials on eggshell membrane involve membranes other than Reggenerate® and focus mainly on joints; our eggshell membrane guide for formulators reviews them.

For a skin formula, the two approaches combine well: a sodium hyaluronate at the dose used in the trials, and a matrix that broadens the formula's profile without weighing down the capsule.

Frequently asked questions

Is fermentation-derived hyaluronic acid synthetic?

No. It is made by bacteria that produce it naturally, then purified, and its structure is identical to that of hyaluronic acid of animal origin. The differences lie in purity, molecular weight and the absence of associated animal proteins.

Can you write “hydrates the skin” on a hyaluronic acid supplement?

No, this claim was rejected at European level. Brands generally pair it with authorized nutrients, such as vitamin C, biotin or zinc, using the exact wording of the register.

Can eggshell membrane replace hyaluronic acid in a formula?

That is not its role. It naturally contains hyaluronic acid, but no published data support the claim that it provides as much as a clinically studied dose of sodium hyaluronate.